Related Experiment Video
Updated: Feb 11, 2026

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice
Published on: March 29, 2024
Circadian Etiology of Type 2 Diabetes Mellitus
Naureen Javeed1, Aleksey V Matveyenko1,2
1Department of Physiology and Biomedical Engineering, Mayo Clinic , Rochester, Minnesota.
Abstract:
The epidemic of Type 2 diabetes mellitus necessitates development of novel therapeutic and preventative strategies to attenuate expansion of this debilitating disease. Evidence links the circadian system to various aspects of diabetes pathophysiology and treatment. The aim of this review will be to outline the rationale for therapeutic targeting of the circadian system in the treatment and prevention of Type 2 diabetes mellitus and consequent metabolic comorbidities.
Insights
Type 2 diabetes requires new treatments. This review explores targeting the body's internal clock, the circadian system, for managing diabetes and related metabolic issues.
Area of Science:
- Chronobiology
- Metabolic Diseases
- Endocrinology
Background:
- Type 2 diabetes mellitus (T2DM) is a growing epidemic requiring novel therapeutic and preventative strategies.
- The circadian system, regulating daily biological rhythms, is increasingly implicated in T2DM pathophysiology.
- Disruptions in circadian rhythms are linked to metabolic dysfunction and diabetes progression.
Purpose of the Study:
- To review the scientific rationale for targeting the circadian system in T2DM.
- To explore the potential of circadian-based interventions for T2DM treatment and prevention.
- To discuss the implications for managing associated metabolic comorbidities.
Main Methods:
- Literature review of studies investigating the interplay between circadian rhythms and T2DM.
- Analysis of evidence linking circadian disruption to diabetes development and progression.
- Synthesis of current research on therapeutic strategies targeting circadian pathways.
Main Results:
- The circadian system significantly influences glucose metabolism, insulin sensitivity, and energy balance.
- Circadian misalignment is associated with increased risk and severity of T2DM.
- Pharmacological and behavioral interventions targeting circadian rhythms show promise in preclinical and clinical studies.
Conclusions:
- Targeting the circadian system represents a promising novel therapeutic avenue for T2DM.
- Circadian-based strategies may offer benefits for both treatment and prevention of T2DM and its comorbidities.
- Further research is warranted to optimize and implement circadian-targeted therapies.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Circadian Rhythms and Gene Regulation
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

